Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine ER vs IR in Smokers
NCT01904526Phase 2Completed
- Sponsor
- Yale University
- Start
- Jul 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in nicotine dependence, sponsored by Yale University. Started Jul 2013; status: completed.
02
Drugs
guanfacine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01904526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01904526.